Nicola E A Chessum

5PUBLICATIONS
62CO-AUTHORS
Haematological tumoursMolecular targetsNonlinear optics and spectroscopyProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors.

Nishma Gupta, Nicole Trainor, Mona Radwan

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Jul 19, 2023
Determination of Ligand-Binding Affinity (Kd) Using Transverse Relaxation Rate (R2) in the Ligand-Observed 1H NMR Experiment and Applications to Fragment-Based Drug Discovery.

Manjuan Liu, Amin Mirza, P Craig McAndrew

|Apr 05, 2023
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.

A Elisa Pasqua, Swee Y Sharp, Nicola E A Chessum

|Dec 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).

Nicola E A Chessum, Swee Y Sharp, John J Caldwell

Pageof 1

Frequent Collaborators

4 joint publications

Matthew D Cheeseman

3 joint publications

Paul Clarke

3 joint publications

Keith Jones

3 joint publications

Paul Workman